Literature DB >> 16773571

Genetic variation in the CCL18-CCL3-CCL4 chemokine gene cluster influences HIV Type 1 transmission and AIDS disease progression.

William S Modi1, James Lautenberger, Ping An, Kevin Scott, James J Goedert, Gregory D Kirk, Susan Buchbinder, John Phair, Sharyne Donfield, Stephen J O'Brien, Cheryl Winkler.   

Abstract

CCL3 (MIP-1 alpha), CCL4 (MIP-1 beta), and CCL18 (DC-CK1/PARC/AMAC-1) are potent chemoattractants produced by macrophages, natural killer cells, fibroblasts, mast cells, CD4(+) T cells, and CD8(+) T cells. CCL3 and CCL4 are natural ligands for the primary human immunodeficiency virus type 1 (HIV-1) coreceptor CCR5 and are also known to activate and enhance the cytotoxicity of natural killer cells. Genomic DNAs from >3,000 participants enrolled in five United States-based natural-history cohorts with acquired immunodeficiency syndrome (AIDS) were genotyped for 21 single-nucleotide polymorphisms (SNPs) in a 47-kb interval on chromosome 17q12 containing the genes CCL3, CCL4, and CCL18. All 21 SNPs were polymorphic in African Americans (AAs), whereas 7 of the 21 had minor-allele frequencies <0.01 in European Americans (EAs). Substantial linkage disequilibrium was observed in a 37-kb interval containing 17 SNPs where many pairwise D' values exceeded 0.70 in both racial groups, but particularly in EAs. Four and three haplotype blocks were observed in AAs and EAs, respectively. Blocks were strongly correlated with each other, and common haplotype diversity within blocks was limited. Two significant associations are reported that replicate an earlier study. First, among AA members of the AIDS Link to the Intravenous Experience cohort of injection drug users, frequencies of three correlated SNPs covering 2,231 bp in CCL3 were significantly elevated among highly exposed, persistently HIV-1-uninfected individuals compared with HIV-1-infected seroconvertors (P = .02-.03). Second, seven highly correlated SNPs spanning 36 kb and containing all three genes were significantly associated with more-rapid disease progression among EAs enrolled in the Multicenter AIDS Cohort Study cohort (P = .01-.02). These results reiterate the importance of chemokine gene variation in HIV-1/AIDS pathogenesis and emphasize that localized linkage disequilibrium makes the identification of causal mutations difficult.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16773571      PMCID: PMC1474130          DOI: 10.1086/505331

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  39 in total

1.  Global survey of genetic variation in CCR5, RANTES, and MIP-1alpha: impact on the epidemiology of the HIV-1 pandemic.

Authors:  E Gonzalez; R Dhanda; M Bamshad; S Mummidi; R Geevarghese; G Catano; S A Anderson; E A Walter; K T Stephan; M F Hammer; A Mangano; L Sen; R A Clark; S S Ahuja; M J Dolan; S K Ahuja
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-24       Impact factor: 11.205

2.  The structure of haplotype blocks in the human genome.

Authors:  Stacey B Gabriel; Stephen F Schaffner; Huy Nguyen; Jamie M Moore; Jessica Roy; Brendan Blumenstiel; John Higgins; Matthew DeFelice; Amy Lochner; Maura Faggart; Shau Neen Liu-Cordero; Charles Rotimi; Adebowale Adeyemo; Richard Cooper; Ryk Ward; Eric S Lander; Mark J Daly; David Altshuler
Journal:  Science       Date:  2002-05-23       Impact factor: 47.728

3.  A comparison of bayesian methods for haplotype reconstruction from population genotype data.

Authors:  Matthew Stephens; Peter Donnelly
Journal:  Am J Hum Genet       Date:  2003-10-20       Impact factor: 11.025

Review 4.  Chemokines--chemotactic cytokines that mediate inflammation.

Authors:  A D Luster
Journal:  N Engl J Med       Date:  1998-02-12       Impact factor: 91.245

5.  Time to initiating highly active antiretroviral therapy among HIV-infected injection drug users.

Authors:  D D Celentano; N Galai; A K Sethi; N G Shah; S A Strathdee; D Vlahov; J E Gallant
Journal:  AIDS       Date:  2001-09-07       Impact factor: 4.177

6.  Novel polymorphisms in human macrophage inflammatory protein-1 alpha (MIP-1alpha) gene.

Authors:  X Xin; K Nakamura; H Liu; E E Nakayama; M Goto; Y Nagai; Y Kitamura; T Shioda; A Iwamoto
Journal:  Genes Immun       Date:  2001-05       Impact factor: 2.676

7.  MCP-1-MCP-3-Eotaxin gene cluster influences HIV-1 transmission.

Authors:  William S Modi; James J Goedert; Steffanie Strathdee; Susan Buchbinder; Roger Detels; Sharyne Donfield; Stephen J O'Brien; Cheryl Winkler
Journal:  AIDS       Date:  2003-11-07       Impact factor: 4.177

8.  Macrophages and lymphocytes differentially modulate the ability of RANTES to inhibit HIV-1 infection.

Authors:  Eleanore Gross; Carol A Amella; Lorena Pompucci; Giovanni Franchin; Barbara Sherry; Helena Schmidtmayerova
Journal:  J Leukoc Biol       Date:  2003-07-15       Impact factor: 4.962

9.  Modulating influence on HIV/AIDS by interacting RANTES gene variants.

Authors:  Ping An; George W Nelson; Lihua Wang; Sharyne Donfield; James J Goedert; John Phair; David Vlahov; Susan Buchbinder; William L Farrar; William Modi; Stephen J O'Brien; Cheryl A Winkler
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-11       Impact factor: 11.205

10.  HIV-1 infection through the CCR5 receptor is blocked by receptor dimerization.

Authors:  A J Vila-Coro; M Mellado; A Martín de Ana; P Lucas; G del Real; C Martínez-A; J M Rodríguez-Frade
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-28       Impact factor: 11.205

View more
  30 in total

Review 1.  Viral quasispecies evolution.

Authors:  Esteban Domingo; Julie Sheldon; Celia Perales
Journal:  Microbiol Mol Biol Rev       Date:  2012-06       Impact factor: 11.056

2.  An effective method for detecting gene conversion events in whole genomes.

Authors:  Chih-Hao Hsu; Yu Zhang; Ross C Hardison; Eric D Green; Webb Miller
Journal:  J Comput Biol       Date:  2010-09       Impact factor: 1.479

3.  CCL3 genotype and current depression increase risk of HIV-associated dementia.

Authors:  Andrew J Levine; Elyse J Singer; Janet S Sinsheimer; Charles H Hinkin; Jeanette Papp; Sugandha Dandekar; Allison Giovanelli; Paul Shapshak
Journal:  Neurobehav HIV Med       Date:  2009-11

Review 4.  HIV and tuberculosis: a deadly human syndemic.

Authors:  Candice K Kwan; Joel D Ernst
Journal:  Clin Microbiol Rev       Date:  2011-04       Impact factor: 26.132

5.  Host genetics contributes to the effectiveness of dendritic cell-based HIV immunotherapy.

Authors:  Edione C Reis; Lais T da Silva; Wanessa C da Silva; Alexandre Rios; Alberto J Duarte; Telma M Oshiro; Sergio Crovella; Alessandra Pontillo
Journal:  Hum Vaccin Immunother       Date:  2018-05-17       Impact factor: 3.452

Review 6.  [Genetic susceptibility to infections].

Authors:  S J Ott; S Schreiber
Journal:  Internist (Berl)       Date:  2011-09       Impact factor: 0.743

7.  Genetic variations and heterosexual HIV-1 infection: analysis of clustered genes encoding CC-motif chemokine ligands.

Authors:  L Hu; W Song; I Brill; J Mulenga; S Allen; E Hunter; S Shrestha; J Tang; R A Kaslow
Journal:  Genes Immun       Date:  2011-10-06       Impact factor: 2.676

Review 8.  Genetic, transcriptomic, and epigenetic studies of HIV-associated neurocognitive disorder.

Authors:  Andrew J Levine; Stella E Panos; Steve Horvath
Journal:  J Acquir Immune Defic Syndr       Date:  2014-04-01       Impact factor: 3.731

Review 9.  Host genetics influences on HIV type-1 disease.

Authors:  Jacques Fellay
Journal:  Antivir Ther       Date:  2009

10.  Multilevel analysis of neuropathogenesis of neurocognitive impairment in HIV.

Authors:  Andrew J Levine; Virawudh Soontornniyomkij; Cristian L Achim; Eliezer Masliah; Benjamin B Gelman; Janet S Sinsheimer; Elyse J Singer; David J Moore
Journal:  J Neurovirol       Date:  2015-12-04       Impact factor: 2.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.